Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
3,803,775
-
Share change
-
+3,250,625
-
Total reported value
-
$79,536,000
-
Price per share
-
$20.91
-
Number of holders
-
18
-
Value change
-
+$67,969,000
-
Number of buys
-
16
Institutional Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q4 2020
As of 31 Dec 2020,
Vincerx Pharma, Inc. - Common Stock (VINC) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,803,775 shares.
The largest 10 holders included
Ikarian Capital, LLC, RTW INVESTMENTS, LP, EcoR1 Capital, LLC, Affinity Asset Advisors, LLC, Holocene Advisors, LP, BOXER CAPITAL, LLC, PERCEPTIVE ADVISORS LLC, Monashee Investment Management LLC, Altium Capital Management LP, and Sio Capital Management, LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.